Developing and Evaluating a Digital Intervention Aiming to Support Informal Caregivers of People With Dementia
NCT ID: NCT07248241
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2025-12-31
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Is it possible to recruit and retain caregivers to participate in this type of digital intervention?
* Do participants find the program relevant, useful, and acceptable? Are the study procedures and outcome measures (such as questionnaires) suitable and manage-able for the participants?
* Does the intervention show preliminary signs of reducing caregiver burden and improving care-givers' wellbeing, knowledge, quality of relationship with the person with dementia, ability to ac-cept the situation, and feelings of being capable of managing their caregiving role? Researchers will compare caregivers who receive the CARE-Dem program with a control group who are offered the usual municipal information sessions. This allows us to see whether the digital pro-gram is feasible and whether it shows signs of effect compared with standard practice.
Participants in the intervention group will be asked to:
• Use the CARE-Dem digital platform over a three-month period.
The platform includes three modules:
Module 1: Understanding dementia and medical treatment options Module 2: Everyday life and communication with a person with dementia Module 3: Legal and practical matters, and information on support available in the community
* Engage with a mix of learning materials such as short videos, fact sheets, interactive activities, guides, and links to further resources
* Complete questionnaires at baseline and after 3 months to measure caregiver burden, wellbeing, and self-efficacy
* Take part in qualitative interviews about their experiences with the program, including usability, satisfaction, acquired knowledge, benefits, and suggestions for improvement.
Participants in the control group will receive treatment as usual. They will be offered to take part in existing information sessions provided by the municipalities, but attendance is optional. Researchers will record whether or not they attend, in order to compare results across subgroups.
This feasibility trial will help determine whether it is possible to run a larger evaluation of the CARE-Dem program in the future. If successful, the program could provide flexible and accessible support to the many caregivers of people with dementia, reaching those who cannot attend traditional in-person sessions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
D-CARE - The Dementia Care Study: A Pragmatic Clinical Trial of Health System-Based Versus Community-Based Dementia Care
NCT03786471
A Support Program for Carers of Persons With Dementia
NCT01287767
Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With Dementia
NCT02397980
Short-term Caregiver Psychotherapy
NCT02175953
Self-management and HeAlth Promotion in Early-stage Dementia With E-learning for Carers
NCT04286139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Participants receive the CARE-Dem intervention
Digital support tool
The CARE-Dem digital support tool offers a number of modules that participants must complete within three months.
Control group
Participants receive treatment as usual and can use available offers
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital support tool
The CARE-Dem digital support tool offers a number of modules that participants must complete within three months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Incapable of collaborating about signing the informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Copenhagen Municipality, Denmark
OTHER_GOV
Municipality of Frederiksberg, Denmark
UNKNOWN
Center for Clinical Research and Prevention
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Geriatrics and Palliation, University Hospital Bispebjerg and Frederiksberg ty Hospital
Frederiksberg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
J.nr. 2024-0040
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CARE-Dem
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.